Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: Association with an aggressive tumour phenotype

Breast Cancer Research and Treatment

Volumn 138, Issue 1, 2013, Pages 81-90

  Karihtala, Peeter ^a   Auvinen, Päivi ^b   Kauppila, Saila ^a   Haapasaari, Kirsi Maria ^a   Jukkola Vuorinen, Arja ^a   Soini, Ylermi ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Epithelial to mesenchymal transition; Prognosis; Transcription factor; Triple negative breast cancer

Indexed keywords

CELL PROTEIN; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; SMAD INTERACTING PROTEIN 1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; VIMENTIN;

ADVANCED CANCER; ARTICLE; BREAST CARCINOGENESIS; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE CHARACTERIZATION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION;

EID: 84874668049     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2442-0     Document Type: Article

References (40)

1. Metzger-Filho O, Tutt A, de Azambuja E et al (2012) Dissecting the heterogeneity of triple-negative breast cancer. J Clin Oncol 30:1879-1987
2. Irshad S, Ellis P, Tutt A (2011) Molecular heterogeneity of triple-negative breast cancer and its clinical implications. Curr Opin Oncol 23:566-577
3. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363:1938-1948
4. Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68:989-997
5. Foroni C, Broggini M, Generali D, Damia G (2012) Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 38:689-697
6. Jeong H, Ryu YJ, An J, Lee Y, Kim A (2012) Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology 60:E87-E95
7. Savagner P (2010) The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol Suppl 7:vii89-vii92
8. Cattoretti G, Andreola S, Clemente C, D'Amato L, Rilke F (1988) Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer 57:353-357
9. Grabitz AL, Duncan MK (2012) Focus on molecules: smad interacting protein 1 (Sip1, ZEB2, ZFHX1B). Exp Eye Res 101:105-106
10. Wakamatsu N, Yamada Y, Yamada K et al (2001) Mutations in Sip1, encoding smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 27:369-370
11. Vandewalle C, Comijn J, De Craene B et al (2005) Sip1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33:6566-6578
12. Remacle JE, Kraft H, Lerchner W et al (1999) New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 18:5073-5084
13. Postigo AA (2003) Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 22:2443-2452
14. Vandewalle C, Van Roy F, Berx G (2009) The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 66:773-787
15. Gheldof A, Hulpiau P, van Roy F, De Craene B, Berx G (2012) Evolutionary functional analysis and molecular regulation of the ZEB transcription factors. Cell Mol Life Sci 69:2527-2541
16. Kim T, Veronese A, Pichiorri F, Lee TJ et al (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting zeb1 and ZEB2. J Exp Med 208:875-883
17. Takkunen M, Grenman R, Hukkanen M, Korhonen M, García de Herreros A, Virtanen I (2006) Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 54:1263-1275
18. Spaderna S, Schmalhofer O, Wahlbuhl M et al (2008) The transcriptional repressor zeb1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68:537-544
19. Merikallio H, Kaarteenaho R, Pääkkö P, Lehtonen S, Hirvikoski P, Mäkitaro R, Harju T, Soini Y (2011) Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J Clin Pathol 64:136-140
20. Jia B, Liu H, Kong Q, Li B (2012) Overexpression of zeb1 associated with metastasis and invasion in patients with gastric carcinoma. Mol Cell Biochem 366:223-229
21. Zhou YM, Cao L, Li B, Zhang RX, Sui CJ, Yin ZF, Yang JM (2012) Clinicopathological significance of zeb1 protein in patients with Hepatocellular Carcinoma. Ann Surg Oncol 19:1700-1706
22. Lemma S, Karihtala P, Haapasaari KM et al (2012) Biological roles and prognostic values of the EMT-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma. Histopathology (in press)
23. Tavassoli FA, Devilee P (eds) (2003) World Health Organization Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, pp 13-59, 63-73
24. Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y (2003) Peroxiredoxins in breast carcinoma. Clin Cancer Res 9:3418-3424
25. Karihtala P, Kauppila S, Soini Y, Jukkola-Vuorinen A (2011) Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer 11:262
26. Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14:1368-1376
27. Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367-5374
28. Al Saleh S, Al Mulla F, Luqmani YA (2011) Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS ONE 6:e20610
29. Kusinska RU, Kordek R, Pluciennik E, Bednarek AK, Piekarski JH, Potemski P (2009) Does vimentin help to delineate the so-called 'basal type breast cancer'? J Exp Clin Cancer Res 28:118
30. Chen MH, Yip GW, Tse GM et al (2008) Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol 21:1183-1191
31. Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M (1990) Vimentinis preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 136:219-227
32. Liu T, Zhang X, Shang M, Zhang Y, Xia B, Niu M, Liu Y, Pang D (2012) Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. J Surg Oncol. doi: 10.1002/jso.23240
33. Greenberg S, Rugo HS (2010) Challenging clinical scenarios: treatment of patients with triple-negative or basal-like metastatic breast cancer. Clin Breast Cancer Suppl 2:S20-S29
34. Bindels S, Mestdagt M, Vandewalle C et al (2006) Regulation of vimentin by Sip1 in human epithelial breast tumor cells. Oncogene 25:4975-4985
35. Miura N, Yano T, Shoji F et al (2009) Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Anticancer Res 29:4099-4106
36. Gemmill RM, Roche J, Potiron VA et al (2011) Zeb1-responsive genes in non-small cell lung cancer. Cancer Lett 300:66-78
37. Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, Mannermaa A, Kosma VM (2011) Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer 16(11):73
38. Geradts J, de Herreros AG, Su Z, Burchette J, Broadwater G, Bachelder RE (2011) Nuclear Snail1 and nuclear zeb1 protein expression in invasive and intraductal human breast carcinomas. Hum Pathol 42:1125-1131
39. Kuroda H, Nakai M, Ohnisi K, Ishida T, Kuroda M, Itoyama S (2010) Vascular invasion in triple-negative carcinoma of the breast identified by endothelial lymphatic and blood vessel markers. Int J Surg Pathol 18:324-329
40. Liu Z, Qi L, Li H, Gao J, Leng X (2012) Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition. Cancer Sci 103:813-820